Dual overlapping peptides recognized by insulin peptide B:9-23 T cell receptor AV13S3 T cell clones of the NOD mouse

被引:51
作者
Abiru, N [1 ]
Wegmann, D [1 ]
Kawasaki, E [1 ]
Gottlieb, P [1 ]
Simone, E [1 ]
Eisenbarth, GS [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA
关键词
autoimmunity; I-A(g7); insulin peptide; NOD mice; T-cell epitope;
D O I
10.1006/jaut.2000.0369
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cells isolated from islets of non-obese diabetic (NOD) mice are enriched for insulin-reactive cells. The great majority of these T cells recognize insulin B chain peptide (B:9-23). B:9-23 reactive T cell clones are diabetogenic and show a dramatic TCR alpha-chain restriction (predominant AV13S3). We have studied the reactivity of five different B:9-23 reactive T cell clones to truncated peptides and alanine substituted analogues of B:9-23. Amongst these AV13S3 T cell clones, one reacted with peptide B:9-16 and four with B:13-23. The two peptides have in common only four amino acids (B:13-16; EALY). Having defined minimal peptide epitopes, we evaluated a mutant insulin sequence (B:13 glutamine) which retains metabolic activity. As predicted, this single amino acid change abrogated T cell reactivity. In addition, we have created a modified I-A(g7) gene with the B:9-23 peptide covalently linked to I-A(g7). Antigen presenting cells transfected with this construct were excellent presenting cells for all clones studied. The definition of dual peptide motifs and creation of bioactive covalent I-A(g7)-B:9-23 should facilitate studies of the pathogenic significance and antigen recognition by B:9-23 reactive diabetogenic T cells. (C) 2000 Academic Press.
引用
收藏
页码:231 / 237
页数:7
相关论文
共 30 条
  • [1] INSULIN-DEPENDENT DIABETES-MELLITUS AS A BETA-CELL TARGETED DISEASE OF IMMUNOREGULATION
    BACH, JF
    [J]. JOURNAL OF AUTOIMMUNITY, 1995, 8 (04) : 439 - 463
  • [2] PREVENTION OF DIABETES IN THE NOD MOUSE - IMPLICATIONS FOR THERAPEUTIC INTERVENTION IN HUMAN-DISEASE
    BOWMAN, MA
    LEITER, EH
    ATKINSON, MA
    [J]. IMMUNOLOGY TODAY, 1994, 15 (03): : 115 - 120
  • [3] MONOMERIC INSULINS AND THEIR EXPERIMENTAL AND CLINICAL IMPLICATIONS
    BRANGE, J
    OWENS, DR
    KANG, S
    VOLUND, A
    [J]. DIABETES CARE, 1990, 13 (09) : 923 - 954
  • [4] ISLET-SPECIFIC T-CELL CLONES FROM NONOBESE DIABETIC MICE EXPRESS HETEROGENEOUS T-CELL RECEPTORS
    CANDEIAS, S
    KATZ, J
    BENOIST, C
    MATHIS, D
    HASKINS, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (14) : 6167 - 6170
  • [5] CarrascoMarin E, 1996, J IMMUNOL, V156, P450
  • [6] CHARACTERIZATION OF INSULIN AUTOANTIBODIES IN RELATIVES OF PATIENTS WITH TYPE-I DIABETES
    CASTANO, L
    ZIEGLER, AG
    ZIEGLER, R
    SHOELSON, S
    EISENBARTH, GS
    [J]. DIABETES, 1993, 42 (08) : 1202 - 1209
  • [7] DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430
  • [8] Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)
    Daniel, D
    Wegmann, DR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (02) : 956 - 960
  • [9] SUPERANTIGENS INTERACT WITH MHC CLASS-II MOLECULES OUTSIDE OF THE ANTIGEN GROOVE
    DELLABONA, P
    PECCOUD, J
    KAPPLER, J
    MARRACK, P
    BENOIST, C
    MATHIS, D
    [J]. CELL, 1990, 62 (06) : 1115 - 1121
  • [10] Phenotypic alterations in insulin-deficient mutant mice
    Duvillie, B
    Cordonnier, N
    Deltour, L
    DandoyDron, F
    Itier, JM
    Monthioux, E
    Jami, J
    Joshi, RL
    Bucchini, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (10) : 5137 - 5140